151 related articles for article (PubMed ID: 23055731)
21. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
[TBL] [Abstract][Full Text] [Related]
22. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
[TBL] [Abstract][Full Text] [Related]
23. In vivo sustained release of siRNA from solid lipid nanoparticles.
Lobovkina T; Jacobson GB; Gonzalez-Gonzalez E; Hickerson RP; Leake D; Kaspar RL; Contag CH; Zare RN
ACS Nano; 2011 Dec; 5(12):9977-83. PubMed ID: 22077198
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.
Zhou L; Chen Z; Wang F; Yang X; Zhang B
Acta Biomater; 2013 Apr; 9(4):6019-31. PubMed ID: 23295402
[TBL] [Abstract][Full Text] [Related]
25. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
Mehrotra N; Tripathi RM
IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
[TBL] [Abstract][Full Text] [Related]
26. siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators.
Giger EV; Castagner B; Räikkönen J; Mönkkönen J; Leroux JC
Adv Healthc Mater; 2013 Jan; 2(1):134-44. PubMed ID: 23184402
[TBL] [Abstract][Full Text] [Related]
27. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
Wang XL; Ramusovic S; Nguyen T; Lu ZR
Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
[TBL] [Abstract][Full Text] [Related]
28. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
29. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
30. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.
Patil ML; Zhang M; Minko T
ACS Nano; 2011 Mar; 5(3):1877-87. PubMed ID: 21322531
[TBL] [Abstract][Full Text] [Related]
32. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.
Conde J; Ambrosone A; Sanz V; Hernandez Y; Marchesano V; Tian F; Child H; Berry CC; Ibarra MR; Baptista PV; Tortiglione C; de la Fuente JM
ACS Nano; 2012 Sep; 6(9):8316-24. PubMed ID: 22882598
[TBL] [Abstract][Full Text] [Related]
33. Disassembly of micelle-like polyethylenimine nanocomplexes for siRNA delivery: High transfection efficiency and reduced toxicity achieved by simple reducible lipid modification.
Guo G; Tortorella M; Zhang B; Wang Y
J Colloid Interface Sci; 2017 Oct; 504():633-644. PubMed ID: 28618383
[TBL] [Abstract][Full Text] [Related]
34. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
[TBL] [Abstract][Full Text] [Related]
35. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Han J; Wang Q; Zhang Z; Gong T; Sun X
Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
[TBL] [Abstract][Full Text] [Related]
36. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.
Yang XZ; Du JZ; Dou S; Mao CQ; Long HY; Wang J
ACS Nano; 2012 Jan; 6(1):771-81. PubMed ID: 22136582
[TBL] [Abstract][Full Text] [Related]
37. Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes.
Nicolì E; Syga MI; Bosetti M; Shastri VP
PLoS One; 2015; 10(4):e0122581. PubMed ID: 25856158
[TBL] [Abstract][Full Text] [Related]
38. Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells.
Tzeng SY; Yang PH; Grayson WL; Green JJ
Int J Nanomedicine; 2011; 6():3309-22. PubMed ID: 22228998
[TBL] [Abstract][Full Text] [Related]
39. Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation.
Lau S; Graham B; Cao N; Boyd BJ; Pouton CW; White PJ
Mol Pharm; 2012 Jan; 9(1):71-80. PubMed ID: 22141328
[TBL] [Abstract][Full Text] [Related]
40. The Effects of Biological Fluids on Colloidal Stability and siRNA Delivery of a pH-Responsive Micellar Nanoparticle Delivery System.
Malcolm DW; Varghese JJ; Sorrells JE; Ovitt CE; Benoit DSW
ACS Nano; 2018 Jan; 12(1):187-197. PubMed ID: 29232104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
